Tuesday, February 23, 2021 3:44:12 PM
You comments regarding the address are valid, but that is not enough to call a company a fake.
ENKS made $22M "net" revenue last year; they have over $96M in assets; and, an additional $39.5M in retained earnings that have not yet been reported as revenue. The $39.5M are earnings held in their overseas accounts and are being used as capital to finance work.
Their financials reflect their past accomplishments and not the value of the future projects, such as the Solar Plant, Hydrogen Plant and 5G network build out that they were awarded in Ukraine.
ENKS work is predominantly overseas and so are the majority of their offices. Their recent PRs explain that their North American addresses are satellite offices.
Their financials have been validated by their lawyer under oath. They will be current in the next few days validating that their disclosures accurately reflect their operations.
You should compare the ENKS balance sheet to other OTC stocks that you feel are stronger. I doubt there are many OTC stocks with stronger financials.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM